Increased levels of γH2AX and p‐RPA32 were also observed after thioparib treatment in the colon cancer HT‐29 (POLQ mutant) cells and PARP‐resistant Capan‐1/TP cells (Appendix Fig S1C and D). Here, PARP1 is linked to malignant colon neoplasm.